Risedronic acid
Top View
- Zoledronic Acid- Reclast and Zometa AHM
- Bisphosphonates and Osteonecrosis of the Jaw: Update on Risk Minimisation Including New Recommendations on Preventative Dental Measures
- Assessment Report for Bisphosphonates Containing Medicinal Products
- Morning Vs Evening Dosing of the Cathepsin K Inhibitor ONO-5334: Effects on Bone Resorption in Postmenopausal Women in a Randomized, Phase 1 Trial
- Appropriate Use of Bisphosphonates in Osteoporosis in Cosenza Health District (Italy) Abstract Code Cpc102 B
- Denosumab (Prolia°) and Steroid-Induced Osteoporosis
- EMEA: CHMP Assessment Report on Bisphosphonates and Osteonecrosis of The
- Use of Drugs Against Osteoporosis in the Baltic Countries During 2010
- CER 53: Treatment to Prevent Fractures in Men and Women with Low Bone Density Or Osteoporosis
- Bone Metabolism Research Reagents Bisphosphonates (Bone Resorption Inhibitors) Non-Nitrogen-Containing Bisphosphonates
- A Literature Review
- The Effect of Cathepsin K Inhibitor on Bone Metabolism
- Summary of Product Characteristics
- South African National Essential Medicine List Hospital Level Medication Review Process Component: Endocrine
- Drugs for the Treatment and Prevention of Osteoporosis in Postmenopausal Women ― Project Protocol
- "Postmenopausal Osteoporosis" OR
- Del. 1.B Final Protocol of a Signal Strengthening Study
- A Rapid Clinical Perspective on Bone-Mineral Density and Osteoporosis